A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

It’ll be a long road to recovery and the treatment is going to be costly. Trevor Reese is 26 years old and is battling ...

Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.

Biden's remark came during a campaign event in Scranton, Penn., in which he talked extensively about Trump and Republican ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

Shuttle Pharmaceuticals has dosed the first three participants in a Phase II trial of Ropidoxuridine for treating ...

CNS Pharmaceuticals (NASDAQ: CNSP) , focused on innovative cancer therapies for brain and central nervous system cancers, recently participated in ...